ISDA

Deposition Date 2008-09-08

Release Date 2009-08-04

Last Version Date 2024-05-08

Entry Detail

PDB ID:

2JLE

Keywords:

TRANSFERASE

Title:

Novel indazole nnrtis created using molecular template hybridization based on crystallographic overlays

Biological Source:

Source Organism:

HUMAN IMMUNODEFICIENCY VIRUS 1 (Taxon ID: 11676)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.90 Å

R-Value Free:

0.35

R-Value Work:

0.26

R-Value Observed:

0.26

Space Group:

C 2 2 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:REVERSE TRANSCRIPTASE/RNASEH
Gene (Uniprot):pol
Chain IDs:A, B
Chain Length:566
Number of Molecules:2
Biological Source:HUMAN IMMUNODEFICIENCY VIRUS 1

UniProt ID:Q72547 Pfam ID:PF00078, PF06817, PF06815, PF00075

Ligand Molecules

I15

Primary Citation

Novel Indazole Non-Nucleoside Reverse Transcriptase Inhibitors Using Molecular Hybridization Based on Crystallographic Overlays.

Jones, L.H, Allan, G, Barba, O, Burt, C, Corbau, R, Dupont, T, Knochel, T, Irving, S, Middleton, D.S, Mowbray, C.E, Perros, M, Ringrose, H, Swain, N.A, Webster, R, Westby, M, Phillips, C.Show

J.Med.Chem. 52 1219 ? (2009)

PMID: 19175319 DOI: 10.1021/JM801322H

Abstact

A major problem associated with non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV is their lack of resilience to mutations in the reverse transcriptase (RT) enzyme. Using structural overlays of the known inhibitors efavirenz and capravirine complexed in RT as a starting point, and structure-based drug design techniques, we have created a novel series of indazole NNRTIs that possess excellent metabolic stability and mutant resilience.

Legend

Protein

Chemical

Disease

Primary Citation of related structures